Invesco Exchange-Traded Fund Trust - Invesco Biotechnology & Genome ETF reported earnings results for the half year ended October 31, 2023. For the half year, the company reported revenue was USD 0.417489 million. Net loss was USD 35.47 million.
Invesco Exchange-Traded Fund Trust - Invesco Dynamic Biotechnology & Genome ETF
Equities
PBE
US46137V7872
Investment Trusts
1st Jan change | Capi. | |
---|---|---|
+3.27% | 14.32B | |
+3.12% | 6.21B | |
+12.72% | 4.4B | |
+10.97% | 4.36B | |
-7.52% | 4B | |
+3.61% | 3.51B | |
+8.55% | 3.22B | |
+7.91% | 3.06B | |
-1.91% | 2.77B |